Literature DB >> 11604495

Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.

M F Chan1, R van Amerongen, T Nijjar, E Cuppen, P A Jones, P W Laird.   

Abstract

Tumor suppressor gene inactivation is a crucial event in oncogenesis. Gene inactivation mechanisms include events resulting in loss of heterozygosity (LOH), gene mutation, and transcriptional silencing. The contribution of each of these different pathways varies among tumor suppressor genes and by cancer type. The factors that influence the relative utilization of gene inactivation pathways are poorly understood. In this study, we describe a detailed quantitative analysis of the three major gene inactivation mechanisms for a model gene at two different genomic integration sites in mouse embryonic stem (ES) cells. In addition, we targeted the major DNA methyltransferase gene, Dnmt1, to investigate the relative contribution of DNA methylation to these various competing gene inactivation pathways. Our data show that gene loss is the predominant mode of inactivation of a herpes simplex virus thymidine kinase neomycin phosphotransferase reporter gene (HSV-TKNeo) at the two integration sites tested and that this event is significantly reduced in Dnmt1-deficient cells. Gene silencing by promoter methylation requires Dnmt1, suggesting that the expression of Dnmt3a and Dnmt3b alone in ES cells is insufficient to achieve effective gene silencing. We used a novel assay to show that missense mutation rates are also substantially reduced in Dnmt1-deficient cells. This is the first direct demonstration that DNA methylation affects point mutation rates in mammalian cells. Surprisingly, the fraction of CpG transition mutations was not reduced in Dnmt1-deficient cells. Finally, we show that methyl group-deficient growth conditions do not cause an increase in missense mutation rates in Dnmt1-proficient cells, as predicted by methyltransferase-mediated mutagenesis models. We conclude that Dnmt1 deficiency and the accompanying genomic DNA hypomethylation result in a reduction of three major pathways of gene inactivation in our model system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604495      PMCID: PMC99930          DOI: 10.1128/MCB.21.22.7587-7600.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  88 in total

1.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Authors:  F Fuks; W A Burgers; A Brehm; L Hughes-Davies; T Kouzarides
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

Review 2.  Gene silencing in the development of cancer.

Authors:  M W McBurney
Journal:  Exp Cell Res       Date:  1999-04-10       Impact factor: 3.905

Review 3.  Pitfalls and practice of Luria-Delbrück fluctuation analysis: a review.

Authors:  W S Kendal; P Frost
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

4.  Comparison of spontaneous hprt mutation spectra at the nucleotide sequence level in the endogenous hprt gene and five other genomic positions.

Authors:  E G Lichtenauer-Kaligis; J Thijssen; H den Dulk; P van de Putte; J G Tasseron-de Jong; M Giphart-Gassler
Journal:  Mutat Res       Date:  1996-04-13       Impact factor: 2.433

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure.

Authors:  R L Yenofsky; M Fine; J W Pellow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase.

Authors:  P Neddermann; P Gallinari; T Lettieri; D Schmid; O Truong; J J Hsuan; K Wiebauer; J Jiricny
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

8.  Role of DNA 5-methylcytosine transferase in cell transformation by fos.

Authors:  A V Bakin; T Curran
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

9.  A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine.

Authors:  M J Yebra; A S Bhagwat
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  22 in total

1.  Gene loss, silencing and activation in a newly synthesized wheat allotetraploid.

Authors:  Khalil Kashkush; Moshe Feldman; Avraham A Levy
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

2.  Reversal of DNA hypomethylation by folic acid supplements: possible role in colorectal cancer prevention.

Authors:  J C Mathers
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  CXXC finger protein 1 contains redundant functional domains that support embryonic stem cell cytosine methylation, histone methylation, and differentiation.

Authors:  Courtney M Tate; Jeong-Heon Lee; David G Skalnik
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

Review 4.  Epigenetic mechanisms of neurodegeneration in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Ki Yoon Kim; Neil W Kowall; Hoon Ryu
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 5.  Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

Authors:  Angelo Fortunato; Amy Boddy; Diego Mallo; Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

6.  Biological functions of DNA methyltransferase 1 require its methyltransferase activity.

Authors:  Marc Damelin; Timothy H Bestor
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

7.  Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein.

Authors:  Diana L Carlone; Jeong-Heon Lee; Suzanne R L Young; Erika Dobrota; Jill Sergesketter Butler; Joseph Ruiz; David G Skalnik
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.

Authors:  D G R Evans; E R Maher; M E Baser
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

9.  Dissection of structure and function of the N-terminal domain of mouse DNMT1 using regional frame-shift mutagenesis.

Authors:  Leonardo D'Aiuto; Marco Marzulli; K Naga Mohan; Ewa Borowczyk; Federica Saporiti; Andrew Vandemark; J Richard Chaillet
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  Studying human telomerase gene transcription by a chromatinized reporter generated by recombinase-mediated targeting of a bacterial artificial chromosome.

Authors:  Shuwen Wang; Yuanjun Zhao; Melanie A Leiby; Jiyue Zhu
Journal:  Nucleic Acids Res       Date:  2009-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.